Top US Court Lifts Discovery Stay On Price-Fixing

Generics Firms Strike Out In Bid To Limit Disclosure Documents

The US Supreme Court has lifted a stay on document discovery in a multi-state lawsuit in which dozens of generics companies – including Teva, Mylan and Pfizer – are accused of price fixing. The ruling will allow a swathe of documents to be released in what Connecticut’s attorney general has said is potentially “the largest cartel case” in US history.

US_Flag_Stop_Barrier
The US Supreme Court has lifted the barrier to full discovery • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin